F-1/A: Lianhe Sowell International Group Ltd Files Amendment for US IPO

Sentiment:

Registration Statement Amendment


Lianhe Sowell International Group Ltd files an amendment to its F-1 registration statement for its initial public offering of ordinary shares on the Nasdaq Capital Market.

Capital raiseThe company plans to offer 2,000,000 ordinary shares in an IPO.The expected initial public offering price is between $4.00 and $5.00 per share.The underwriters have an option to purchase up to an additional 15% of the shares to cover over-allotments.

Summary

  • Lianhe Sowell International Group Ltd, a Cayman Islands company, has filed an amendment to its F-1 registration statement with the SEC for an IPO.
  • The company plans to offer 2,000,000 ordinary shares, with an expected initial public offering price between $4.00 and $5.00 per share.
  • The company will apply to list its Ordinary Shares on the Nasdaq Capital Market under the symbol LHSW.
  • The company is an emerging growth company and will be subject to reduced public company reporting requirements.
  • The company conducts substantially all of its operations through its PRC subsidiaries.
  • The company has timely submitted the filing with the CSRC as per requirement of the New Administrative Rules Regarding Overseas Listings, and the CSRC published the notification on our completion of the required filing procedures on May 30, 2024.
  • The company has granted the underwriters an option to purchase up to an additional 15% of the Ordinary Shares offered in this offering on the same terms to cover over-allotments, if any.
  • The company has agreed to sell to the Representative, on the applicable closing date of this offering, warrants in an amount equal to 3% of the aggregate number of Ordinary Shares sold by us in this offering (the Representatives Warrants).

Sentiment

Score: 6

Explanation: The document is mostly neutral, presenting facts about the company's IPO plans. The inclusion of risk factors and regulatory uncertainties slightly lowers the sentiment.

Positives

  • The company has timely submitted the filing with the CSRC as per requirement of the New Administrative Rules Regarding Overseas Listings, and the CSRC published the notification on our completion of the required filing procedures on May 30, 2024.

Negatives

  • Investors in our Ordinary Shares should be aware that they may never hold equity interests in any PRC operating entities.
  • The PRC government recently initiated a series of regulatory actions and made a number of public statements on the regulation of business operations in China.
  • Our PRC counsel has advised that the offering will be identified as an indirect overseas issuance and listing under the New Administrative Rules Regarding Overseas Listings and the company is therefore subject to the approval, filing or other requirements of the CSRC in connection with this offering.
  • The company cannot assure that it will be able to complete such filings in a timely manner, or even at all, and future offerings will be contingent upon the completion of the filing procedures.
  • Our Ordinary Shares may be prohibited to trade on a national exchange or over-the-counter markets under the Holding Foreign Companies Accountable Act (the HFCA Act) if the Public Company Accounting Oversight Board (the PCAOB) is unable to inspect our auditors for three consecutive years beginning in 2021.

Risks

  • Investors may never hold equity interests in any PRC operating entities.
  • The company is subject to regulatory actions and public statements on the regulation of business operations in China.
  • The company is subject to the approval, filing or other requirements of the CSRC in connection with this offering.
  • The company cannot assure that it will be able to complete such filings in a timely manner, or even at all, and future offerings will be contingent upon the completion of the filing procedures.
  • The company's Ordinary Shares may be prohibited from trading if the PCAOB is unable to inspect their auditors for three consecutive years.

Future Outlook

The company plans to list its Ordinary Shares on the Nasdaq Capital Market, but there is no assurance that this will occur.

Industry Context

The announcement relates to the broader trend of Chinese companies seeking listings on U.S. stock exchanges, while navigating increasing regulatory scrutiny from both U.S. and Chinese authorities.

Stakeholder Impact

  • Potential investors should be aware of the risks associated with investing in a China-based company.
  • Existing shareholders may experience dilution as a result of the IPO.

Next Steps

  • The company will apply to list its Ordinary Shares on the Nasdaq Capital Market.
  • The company will proceed with the IPO, subject to market conditions and regulatory approvals.

Key Dates

DateDescription
2021Beginning of the period for HFCA Act compliance regarding PCAOB inspections.
February 17, 2023CSRC issued Trial Administrative Measures of Overseas Securities Offering and Listing by Domestic Companies.
February 24, 2023CSRC promulgated the Provisions on Strengthening Confidentiality and Archives Administration of Overseas Securities Offering and Listing by Domestic Companies.
March 31, 2023Effective date of the Trial Administrative Measures of Overseas Securities Offering and Listing by Domestic Companies and the Provisions on Strengthening Confidentiality and Archives Administration of Overseas Securities Offering and Listing by Domestic Companies.
May 30, 2024CSRC published the notification on the company's completion of the required filing procedures.

Keywords

IPO, ordinary shares, CSRC, PCAOB, HFCA Act, China, Lianhe Sowell International Group Ltd, filing, registration statement, offering

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.